I am recommending we roll our Best Buy (BBY) and SPDR S&P Biotech ETF (XBI) puts. We are going out two weeks due to next week’s Federal Reserve meeting. While the Fed is widely expected to raise rates 0.75%, the market could move sharply in either direction based on the actual size of the rate…
Our SPDR S&P Biotech ETF (XBI) put expired worthless last week. I am recommending a new put to sell to generate more income and reduce our net debit on the position. You can enter the second leg of today’s trade even if you were not in the previous one. Just be aware that we will…
We have puts on Apple (AAPL), Moderna (MRNA) and SPDR S&P Biotech ETF (XBI) expiring today. AAPL has sold off with the rest of the tech sector. As I said when we put on the position, the plan was to accept shares if the call was in the money heading into expiration. I will be…
I am recommending we roll our First Solar (FSLR), Mosaic Company (MOS), Nike (NKE) and SPDR S&P Biotech ETF (XBI) puts to generate more income and reduce our net debits on the positions. You can enter the second leg of today’s trades even if you were not in the previous ones. Just be aware that…
I am recommending we roll our SPDR S&P Biotech ETF (XBI) put out two weeks to generate more income and lower our net debit on the position. You can enter the second leg of today’s trade even if you were not in the previous one. Just be aware that we will be managing and tracking…
I am recommending selling puts on Best Buy (BBY) and SPDR S&P Biotech ETF (XBI) to reduce our net debits on the positions. BBY is rallying today with the broader market despite the company cutting its outlook for the second quarter and full year. Management also said they will pause share buybacks, although Best Buy…
I want to temporarily close the short leg of our Expedia (EXPE) bull put spread, as well as our Moderna (MRNA) and SPDR S&P Biotech ETF (XBI) puts ahead of today’s Federal Reserve announcement. While the market seems to have priced in 75-basis-point rate increases in July and September and is rallying today, we could…
I am recommending we roll our Moderna (MRNA) and SPDR S&P Biotech ETF (XBI) puts out one week. The income we generate will reduce our net debit on the positions. However, you can enter the second leg of today’s trades even if you were not in the previous ones. Just be aware that we will…
I am recommending we roll our SPDR S&P Biotech ETF (XBI) put out one week and to a higher strike to generate more income and reduce our net debit on the position. Note that this trade is only for members already in the position. Current Stock Price: $81.48 Net Debit: $14.36 Action: Buy to close…
Our SPDR S&P Biotech ETF (XBI) shares were called away after a run-up in the sector took the ETF well above our call’s strike. Now that the rally appears to have stalled, it’s time to sell a put to generate income and reduce our net debit on the position. You can enter today’s trade even…
